ReviewDrug discovery today. Technologies2013

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.

A L Lublin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.